Spots Global Cancer Trial Database for emd 525797 250 mg
Every month we try and update this database with for emd 525797 250 mg cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
EMD 525797 in Combination With Cetuximab and Irinotecan in K-ras Wild Type Metastatic Colorectal Cancer | NCT01008475 | Metastatic Colo... | EMD 525797 250 ... EMD 525797 500 ... EMD 525797 750 ... EMD 525797 1000... Cetuximab Irinotecan | 18 Years - | Merck KGaA, Darmstadt, Germany |